CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


blood sample for seroepidemiological investigationWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (4)


Name (Synonyms) Correlation
drug331 BBV152B Wiki 1.00
drug330 BBV152A Wiki 1.00
drug332 BBV152C Wiki 1.00
drug2122 Placebo Wiki 0.05

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 SARS-CoV2 (COVID-19) Seroepidemiological Investigation in Transplanted Population Subjects of Kidney, Kidney-pancreas, Isolated Pancreas, Langerhans Islets

Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.

NCT04487197 Kidney Transplant Pancreatic Transplat Pancreatic Pancreatic Islets Langerhans Procedure: blood sample for seroepidemiological investigation

Primary Outcomes

Description: Evaluation of serum-prevalence data transplanted patients (symptomatic vs asymptomatic patients)

Measure: Serum-prevalence of COVID-19 TX

Time: From 15 July 2020 to 15 January 2021

Description: Correlation serum-prevalence of COVID-19 / Age, Gender, Type of transplantation, comorbities, Italian regions-proviences transplanted patients

Measure: Serum-prevalence of COVID-19 / Age, Gender, Type of transplantation, comorbities, Italian regions-proviences transplanted patients

Time: From 15 July 2020 to 15 January 2021

Secondary Outcomes

Description: Determine % Asymptomatic or subclinical infections in transplanted patients

Measure: Asymptomatic or subclinical infections in transplanted patients

Time: From 15 July 2020 to 15 January 2021

Description: Determine risk factors for infection COVID-19 (comparison symtomatic and asymtomatic transplanted patients)

Measure: Risk factors for infection COVID-19 transplanted patients

Time: From 15 July 2020 to 15 January 2021

Description: Evaluate hospitalization rate in transplanted patients

Measure: Hospitalization rate COVID-19 transplanted patients

Time: From 15 July 2020 to 15 January 2021

Description: Evaluate mortality rate in transplanted patients

Measure: Mortality rate COVID-19 transplanted patients

Time: From 15 July 2020 to 15 January 2021


No related HPO nodes (Using clinical trials)